K&S Global Health Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
as on 09-01-2025
- Paid Up Capital ₹ 5.00 Cr
as on 09-01-2025
- Company Age 2 Year,
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 26.50 Cr
as on 09-01-2025
About K&S Global Health
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 5.00 Cr.
The company currently has active open charges totaling ₹26.50 Cr.
Balwinder Pal, Ritika Khanna, Jogesh Agarwala, and One other member serve as directors at the Company.
- CIN/LLPIN
U85110PB2023PTC057679
- Company No.
057679
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Jan 2023
- Date of AGM
28 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Company Details
- Location
Rupnagar, Punjab, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at K&S Global Health?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Balwinder Pal  | Director | 27-Mar-2023 | Current |
| Ritika Khanna | Director | 11-Jan-2023 | Current |
| Jogesh Agarwala | Director | 27-Mar-2023 | Current |
| Ramandeep Singh | Director | 11-Jan-2023 | Current |
Financial Performance of K&S Global Health.
K&S Global Health Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of K&S Global Health?
In 2023, K&S Global Health had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Chandigarh Healthcare Private LimitedActive 13 years 6 monthsBalwinder Pal and Ramandeep Singh are mutual person
Indus Super Speciality Healthcare Private LimitedActive 15 years 8 monthsRamandeep Singh is a mutual person
Rsr Health Vell Speciality Hospital Private LimitedActive 3 months 19 daysBalwinder Pal is a mutual person
- Indus Super Speciality LlpActive 3 years 2 months
Ritika Khanna and Ramandeep Singh are mutual person
- Indus Super Healthcare LlpActive 2 years 11 months
Ritika Khanna and Ramandeep Singh are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 26 May 2023 | ₹26.50 Cr | Open |
How Many Employees Work at K&S Global Health?
Unlock and access historical data on people associated with K&S Global Health, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of K&S Global Health, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped K&S Global Health's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
